Pro-Dex (PDEX) Expected to Release Quarterly Earnings on Monday

Pro-Dex (NASDAQ:PDEX) is expected to release its Q4 2026 results after the market closes on Monday, August 31st. Analysts expect the company to announce earnings of $0.67 per share and revenue of $19.20 million for the quarter. Investors may review the information on the company’s upcoming Q4 2026 earning report for the latest details on the call scheduled for Friday, September 4, 2026 at 4:00 PM ET.

Pro-Dex Trading Down 3.5%

Shares of Pro-Dex stock opened at $62.56 on Friday. The company’s fifty day simple moving average is $61.96 and its 200-day simple moving average is $55.94. The stock has a market capitalization of $199.57 million, a PE ratio of 17.28 and a beta of 0.02. Pro-Dex has a 1-year low of $23.47 and a 1-year high of $69.86. The company has a debt-to-equity ratio of 0.32, a current ratio of 3.67 and a quick ratio of 2.14.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Zacks Research upgraded Pro-Dex to a “hold” rating in a research note on Tuesday, May 19th. Ascendiant Capital Markets boosted their price target on Pro-Dex from $56.00 to $70.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. Weiss Ratings lowered Pro-Dex from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, August 24th. Finally, Wall Street Zen upgraded Pro-Dex from a “hold” rating to a “buy” rating in a research report on Saturday, June 13th. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $70.00.

Hedge Funds Weigh In On Pro-Dex

Hedge funds have recently modified their holdings of the company. Quadrature Capital Ltd bought a new stake in shares of Pro-Dex during the 4th quarter valued at $220,000. Osaic Holdings Inc. lifted its stake in shares of Pro-Dex by 44.8% during the 4th quarter. Osaic Holdings Inc. now owns 11,434 shares of the medical instruments supplier’s stock valued at $440,000 after buying an additional 3,540 shares in the last quarter. Royal Bank of Canada boosted its holdings in Pro-Dex by 603.4% in the 4th quarter. Royal Bank of Canada now owns 4,080 shares of the medical instruments supplier’s stock worth $157,000 after buying an additional 3,500 shares during the period. First Trust Advisors LP bought a new position in Pro-Dex in the 4th quarter worth $222,000. Finally, Wells Fargo & Company MN increased its stake in Pro-Dex by 65.4% in the 4th quarter. Wells Fargo & Company MN now owns 2,314 shares of the medical instruments supplier’s stock worth $89,000 after buying an additional 915 shares in the last quarter. 15.28% of the stock is currently owned by institutional investors.

About Pro-Dex

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.